The same is true for other emerging technologies that also show higher sensitivity than Sanger Sequencing, such as next generation sequencing (NGS), that have been used to identify genetic alteration in genes other than TERT and that have been associated with aggressive thyroid tumors subtype (40). The gene discussed is TERT; the disease is thyroid tumor.